Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 608

1.

Systemic treatment of neuroendocrine tumors with hepatic metastases.

Demirkan BH, Eriksson B.

Turk J Gastroenterol. 2012;23(5):427-37. Review.

2.

[Pharmacologic therapy for neuroendocrine tumours].

Petrányi A, Bodoky G.

Orv Hetil. 2011 Mar 6;152(10):379-91. doi: 10.1556/OH.2011.29060. Review. Hungarian.

PMID:
21354954
3.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
4.

Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas.

Fazio N, Cinieri S, Lorizzo K, Squadroni M, Orlando L, Spada F, Maiello E, Bodei L, Paganelli G, Delle Fave G, de Braud F.

Cancer Treat Rev. 2010 Nov;36 Suppl 3:S87-94. doi: 10.1016/S0305-7372(10)70026-8. Review.

PMID:
21129617
5.

Novel therapeutic agents for the treatment of gastroenteropancreatic neuroendocrine tumors.

Pavel ME, Wiedenmann B.

Horm Metab Res. 2011 Nov;43(12):844-53. doi: 10.1055/s-0031-1291368. Epub 2011 Nov 21. Review.

PMID:
22105475
6.

Endocrine tumors of the gastrointestinal tract: systemic treatment.

Oberg K.

Anticancer Drugs. 1994 Oct;5(5):503-19. Review.

PMID:
7858282
7.

Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system.

Faiss S, Scherübl H, Riecken EO, Wiedenmann B.

Recent Results Cancer Res. 1996;142:193-207. Review.

PMID:
8893342
8.

Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.

Faivre S, Sablin MP, Dreyer C, Raymond E.

Endocrinol Metab Clin North Am. 2010 Dec;39(4):811-26. doi: 10.1016/j.ecl.2010.09.006. Review.

PMID:
21095547
9.

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial.

Mitry E, Walter T, Baudin E, Kurtz JE, Ruszniewski P, Dominguez-Tinajero S, Bengrine-Lefevre L, Cadiot G, Dromain C, Farace F, Rougier P, Ducreux M.

Eur J Cancer. 2014 Dec;50(18):3107-15. doi: 10.1016/j.ejca.2014.10.001. Epub 2014 Oct 18.

PMID:
25454413
10.

A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours.

Strosberg JR, Kvols LK.

Expert Opin Investig Drugs. 2007 Feb;16(2):219-24. Review.

PMID:
17243941
11.

New treatment strategies in advanced neuroendocrine tumours.

Walter T, Brixi-Benmansour H, Lombard-Bohas C, Cadiot G.

Dig Liver Dis. 2012 Feb;44(2):95-105. doi: 10.1016/j.dld.2011.08.022. Epub 2011 Oct 7. Review.

PMID:
21983252
12.

Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.

Miljković MD, Girotra M, Abraham RR, Erlich RB.

Dig Dis Sci. 2012 Jan;57(1):9-18. doi: 10.1007/s10620-011-1854-0. Epub 2011 Sep 22. Review.

PMID:
21938486
13.

New developments in the treatment of gastrointestinal neuroendocrine tumors.

Kulke MH.

Curr Oncol Rep. 2007 May;9(3):177-83. Review.

PMID:
17430688
14.

Gastrointestinal neuroendocrine tumors: a role for targeted therapies?

Kulke MH.

Endocr Relat Cancer. 2007 Jun;14(2):207-19. Review.

15.

[Surgical and adjuvant therapy of neuroendocrine tumors of the gastrointestinal tract and their metastases. A retrospective analysis of personal patient group].

Schmidbauer S, Ladurner R, Jückstock H, Trupka AW, Mussack T, Hallfeldt KK.

Chirurg. 2001 Aug;72(8):945-52. German.

PMID:
11554141
16.

Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors.

Raymond E, Hobday T, Castellano D, Reidy-Lagunes D, García-Carbonero R, Carrato A.

Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:19-26. doi: 10.1007/s10555-011-9291-2.

PMID:
21308478
17.

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.

Chan HY, Grossman AB, Bukowski RM.

Adv Ther. 2010 Aug;27(8):495-511. doi: 10.1007/s12325-010-0045-2. Epub 2010 Jul 8. Review.

PMID:
20623346
18.

New drugs in neuroendocrine tumors: rising of new therapeutic philosophies?

Eriksson B.

Curr Opin Oncol. 2010 Jul;22(4):381-6. doi: 10.1097/CCO.0b013e32833adee2. Review.

PMID:
20473165
19.

Therapeutic strategies for neuroendocrine liver metastases.

Frilling A, Clift AK.

Cancer. 2015 Apr 15;121(8):1172-86. doi: 10.1002/cncr.28760. Epub 2014 Oct 1. Review.

20.

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors.

Delaunoit T, Rubin J, Neczyporenko F, Erlichman C, Hobday TJ.

Mayo Clin Proc. 2005 Apr;80(4):502-6. Review.

PMID:
15819288

Supplemental Content

Support Center